Five Prime Therapeutics Inc
Anti-CSF1R antibody and anti PD-1 antibody combination therapy for cancer
Last updated:
Abstract:
Methods of treating cancer with antibodies that bind colony stimulating factor 1 receptor (CSF1R) in combination with PD-1/PD-L1 inhibitors are provided.
Status:
Grant
Type:
Utility
Filling date:
9 Jan 2019
Issue date:
14 Apr 2020